查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
注意力缺陷多動障礙市場規模、份額和趨勢分析報告：按藥物類型（興奮劑、非興奮劑）、人口統計（兒童、成人）、分銷渠道、地區、細分市場預測，2023-2030 年
市場調查報告書
商品編碼
1171025

注意力缺陷多動障礙市場規模、份額和趨勢分析報告：按藥物類型（興奮劑、非興奮劑）、人口統計（兒童、成人）、分銷渠道、地區、細分市場預測，2023-2030 年

Attention Deficit Hyperactivity Disorder Market Size, Share & Trends Analysis Report By Drug Type (Stimulants, Non-stimulants), By Demographics (Children, Adults), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 114 Pages | 商品交期: 2-10個工作天內

價格

注意力缺陷多動障礙市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球注意力缺陷多動障礙市場預計將達到 186.9 億美元。從 2023 年到 2030 年，該市場預計將以 4.2% 的複合年增長率增長。用於 ADHD 治療的強大產品線的存在和隨後的批准預計將推動市場增長。後期管線包括Neurocentria, Inc.開發的NRCT-101、Supernus Pharmaceuticals, Inc.的SPN-812和Otsuka America Pharmaceutical, Inc.的EB-1020。

政府機構就 ADHD 的早期診斷和治療採取的幾項舉措可能會支持市場的增長。2021 年 1 月，澳大利亞政府將 Vyvanse 納入藥物福利計劃（PBS），用於治療成人多動症。這一納入使得 Vyvanse 能夠為患者提供補貼，使 20,000 多名患者能夠以更低的成本從可比的疾病治療中受益。如果沒有 PBS 補貼，患者每年將不得不支付超過 1,200 美元的治療費用。一旦納入 PBS，治療費用為每單位 41.30 美元。預計這些努力也將促進市場的增長。

患者、醫生和其他醫療保健專業人員對 ADHD 的認識不斷提高可能會增加對診斷和治療的需求，從而推動注意力缺陷多動障礙市場的增長。注意缺陷多動障礙教練組織 (ACO) 將 10 月定為 ADHD 宣傳月，旨在提高人們的認識，為研究和開發籌集資金，並教育人們了解這種疾病。相信這一努力將促進早期診斷並促進產品的吸收。

然而，患有 ADHD 的兒童患其他精神疾病的風險增加，常常使診斷和治療複雜化。Lundbeck 基金會在 2021 年發表的一項研究發現，患有其他精神障礙的 ADHD 患者更有可能避免服用藥物。多動症兒童常見的合併症包括抑鬱症、焦慮症、躁鬱症、學習障礙、早期語言和交流障礙以及對立任務障礙。

此外，治療 ADHD 的興奮劑短缺迫使患者支付昂貴的品牌藥物費用，為行為療法等替代療法創造空間，對 ADHD 藥物治療的需求產生負面影響。美國緝毒局 (DEA) 等監管機構實施了嚴格的規定，包括限制 ADHD 藥物的生產以避免誤用和濫用。需求上升可能導致處方藥短缺，從而導致更高的治療成本並抑制市場增長。因此，藥物短缺會阻礙市場增長。

注意力缺陷多動障礙市場報告要點

按藥物類型劃分，由於對這些藥物和症狀管理的高需求、政府對使用興奮劑藥物的支持以及正在進行的注意力缺陷多動障礙臨床試驗，興奮劑部分將在 2022 年成為市場上最大的部分

根據人口統計數據，由於目標人群龐大且患注意力缺陷多動障礙的風險高，成人細分市場在 2022 年主導了注意力缺陷多動障礙市場。據 ADD Health and Wellness Centers, Inc. 稱，這種疾病影響了大約 4-5% 的成年人口

預計 2022 年的注意力缺陷多動障礙市場將在預測期內呈現最快的增長，零售藥房領域將佔據主導地位。這是由於零售藥店中註意力缺陷多動障礙藥物的廣泛供應以及患者獲取的便利性。

由於醫療保健專業人員對可用治療藥物的認識高以及疾病流行率上升等因素，北美在 2022 年主導了全球市場。根據加拿大多動症意識中心 (CADDAC) 的數據，加拿大有超過 150 萬人患有這種疾病

由於多動症患病率和治療需求的增加，預計亞太地區將成為預測期內增長最快的地區。例如，多動症是最常見的神經發育障礙之一，在澳大利亞約有 8.2% 的兒童和 11% 的男孩被確診。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 段範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 第一次調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法：產品流方法
  • 調查假設
  • 二級信息列表
  • 縮略語表
  • 目的

第二章執行摘要

  • 市場快照
  • 段快照
  • 爭用快照

第 3 章註意力缺陷多動障礙：市場變量、趨勢和範圍

  • 市場系列展望
    • 中樞神經系統藥物市場
  • 繪製滲透率和增長前景
  • 監管狀況
  • 市場動態
  • 市場驅動力分析
    • 多動症患病率增加
    • 提高醫生和患者對多動症的認識
  • 市場約束因素分析
    • 多動症藥物短缺
    • 非興奮劑 ADHD 藥物的可用性低
    • 導致兒童漏診的合併症
  • PESTEL 分析
  • 行業分析——波特五力
  • 管道分析

4. 注意力缺陷多動障礙市場：細分分析，按藥物類型，2018-2030 年（百萬美元）

  • 注意力缺陷多動障礙市場：藥物類型變化分析
  • 興奮劑系統
    • 苯丙胺
    • □醋甲酯
    • Lisdexamphetamine
    • □醋甲酯
  • 非興奮劑
    • 托莫西汀
    • 胍法辛
    • 可樂定
    • 其他

5. 注意力缺陷多動障礙市場：細分分析，按人口統計，2018-2030 年（百萬美元）

  • 注意力缺陷多動障礙市場：人口統計分析
  • 孩子
  • 成人

6. 注意力缺陷多動障礙市場：細分分析，按分銷渠道，2018-2030 年（百萬美元）

  • 注意力缺陷/多動障礙市場：分銷渠道波動分析
  • 零售藥店
  • 醫院藥房

7. 注意力缺陷多動障礙市場：按地區劃分的細分分析，2018-2030 年（百萬美元）

  • 區域市場快照
  • 2022 年和 2030 年區域市場份額分析
  • 市場規模、預測以及收入和趨勢分析，2022-2030 年
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 澳大利亞
      • 韓國
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多邊環境協定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

8.注意力缺陷多動障礙市場：競爭分析

  • 主要市場進入者的最新發展和影響分析
    • 協同效應分析：重大交易和戰略聯盟
      • 新產品發布
      • 併購
      • 許可協議
  • 公司分類
    • 創新者
    • 市場領導者
    • 新興玩家
    • 熱圖分析
  • 公司市場分析
  • 供應商情況
    • 主要經銷商及渠道合作夥伴名單
    • 潛在最終用戶列表
    • 2022 年主要參與者的市場份額分析
    • 消費者行為分析
    • 競爭儀錶盤分析
  • 民營企業
    • 主要初創企業名單
    • 區域網絡圖
  • 公司簡介
    • Pfizer, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 最近的發展
    • Johnson & Johnson Services, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 最近的發展
    • Lupin
      • 公司簡介
      • 財務績效
      • 產品基準
      • 最近的發展
    • Novartis AG
      • 公司簡介
      • 財務績效
      • 產品基準
      • 最近的發展
    • Takeda Pharmaceutical Company Limited
      • 公司簡介
      • Shire
      • 財務績效
      • 產品基準
      • 最近的發展
    • Mallinckrodt plc.
      • 公司簡介
      • 財務績效
      • 產品基準
    • Purdue Pharma Lp
      • 公司簡介
      • 產品基準
    • NEOS Therapeutics, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 最近的發展
    • Supernus Pharmaceuticals, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 最近的發展
Product Code: GVR-2-68038-795-7

Attention Deficit Hyperactivity Disorder Market Growth & Trends:

The global attention deficit hyperactivity disorder market size is expected to reach USD 18.69 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.2% from 2023 to 2030. The presence of a strong product pipeline for the treatment of ADHD and their subsequent approval is expected to boost the market growth. Some late-stage pipeline products are NRCT-101 developed by Neurocentria, Inc., SPN-812 by Supernus Pharmaceuticals, Inc., and EB-1020 by Otsuka America Pharmaceutical, Inc.

Several initiatives undertaken by government bodies regarding early diagnosis and treatment of ADHD are likely to support the market growth. In January 2021, the Australian Government included Vyvanse under its Pharmaceutical Benefits Scheme (PBS) for the treatment of adult patients with ADHD. This inclusion makes the availability of Vyvanse at a subsidized rate to patients and more than 20,000 patients received a comparable treatment for the disease at low cost and benefits. Without PBS subsidy, the patients had to pay more than USD 1,200 per person annually for their treatment. After the inclusion in PBS, they will receive the treatment at USD 41.30 per script. Such initiatives are also expected to drive market growth.

Increasing awareness about ADHD among patients, physicians, and other healthcare providers may increase the demand for diagnosis and treatment which in turn propel the growth of the attention deficit hyperactivity disorder market. The Attention Deficit Hyperactivity Disorder Coaches Organization (ACO) celebrates October as the ADHD awareness month intending to raise awareness, generate funding for R&D, and educate people about disorders. This initiative may boost early diagnosis, thereby, increasing product penetration.

However, the risk of comorbidity with other psychiatric disorders is high among children with ADHD, often making diagnosis and treatment of the disorder complex. A research study published by the Lundbeck Foundation in 2021 showed that ADHD patients with other psychiatric comorbid conditions were more likely to avoid taking medicines. Some of the comorbid conditions that typically occur in ADHD pediatric patients are depression, anxiety, bipolar disorder, learning disorder, early speech/communication problems, and oppositional defiant disorder.

Furthermore, the shortage of stimulants to treat ADHD has forced patients to pay for expensive branded medication and create scope for substitute therapies, such as behavioral therapy, which will negatively impact the demand for ADHD pharmacological therapies. Strict regulations are implemented by regulatory bodies, such as the U.S. Drug Enforcement Administration (DEA), which limit the production of ADHD drugs to avoid misuse or abuse. Amid an increase in demand, this can create a shortage of medical products, consequently increasing the cost of treatments and restraining market growth. Thus, the shortage of medicines may impede the market growth.

Attention Deficit Hyperactivity Disorder Market Report Highlights:

  • By drug type, the stimulants segment accounted for the largest share of the market in 2022 due to the high demand for these medicines and the management of symptoms, government support for the use of stimulants drugs, and continuing clinical trials regarding attention deficit hyperactive disorder
  • Based on demographics, the adults segment dominated the attention-deficit hyperactivity disorder market in 2022 owing to the large target population base and high risk of developing the attention-deficit hyperactive disorder. According to ADD Health and Wellness Centers, Inc. the disorder affects approximately 4-5% of the adult population
  • Retail pharmacy segment dominated the attention-deficit hyperactivity disorder market in 2022 and is anticipated to witness the fastest growth over the forecast period. This can be attributed to the wide availability of attention deficit hyperactivity disorder drugs at retail pharmacies and their ease of accessibility to patients
  • North America dominated the global market in 2022 owing to factors such as high awareness among healthcare professionals about drugs available for treatment and the rise in disease prevalence. According to the Center for ADHD Awareness Canada (CADDAC), more than 1.5 million people are affected by the disease in Canada
  • Asia Pacific is expected to be the fastest-growing region during the forecast period to increasing ADHD prevalence and treatment demand in the region. For instance, ADHD is one of the most common neurodevelopment diseases with approximately 8.2% of children and 11% of boys diagnosed in Australia

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation and Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Attention Deficit Hyperactivity Disorder: Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Central Nervous System Therapeutics Market
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Regulatory Landscape
  • 3.4 Market Dynamics
  • 3.5 Market Driver Analysis
    • 3.5.1 Increasing Prevalence of ADHD
    • 3.5.2 Increasing Awareness About ADHD Among Physicians and Patients
  • 3.6 Market Restraint Analysis
    • 3.6.1 Shortage of ADHD Drugs
    • 3.6.2 Low Availability of Non-stimulant ADHD Drugs
    • 3.6.3 Comorbidities Leading to Underdiagnosis in Children
  • 3.7 PESTEL Analysis
  • 3.8 Industry Analysis - Porter's Five Forces
  • 3.9 Pipeline Analysis

Chapter 4 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Drug Type, 2018 - 2030 (USD Million)

  • 4.1 Attention Deficit Hyperactivity Disorder Market: Drug Type Movement Analysis
  • 4.2 Stimulants
    • 4.2.1 Stimulants Market, 2018 - 2030 (USD Million)
    • 4.2.2 Amphetamine
      • 4.2.2.1 Amphetamine Market, 2018 - 2030 (USD Million)
    • 4.2.3 Methylphenidate
      • 4.2.3.1 Methylphenidate Market, 2018 - 2030 (USD Million)
    • 4.2.4 Lisdexamfetamine
      • 4.2.4.1 Lisdexamfetamine Market, 2018 - 2030 (USD Million)
    • 4.2.5 Dexmethylphenidate
      • 4.2.5.1 Dexmethylphenidate Market, 2018 - 2030 (USD Million)
  • 4.3 Non - Stimulants
    • 4.3.1 Non - stimulants Market, 2018 - 2030 (USD Million)
    • 4.3.2 Atomoxetine
      • 4.3.2.1 Atomoxetine Market, 2018 - 2030 (USD Million)
    • 4.3.3 Guanfacine
      • 4.3.3.1 Guanfacine Market, 2018 - 2030 (USD Million)
    • 4.3.4 Clonidine
      • 4.3.4.1 Clonidine Market, 2018 - 2030 (USD Million)
    • 4.3.5 Others
      • 4.3.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Demographic, 2018 - 2030 (USD Million)

  • 5.1 Attention Deficit Hyperactivity Disorder Market: Demographics Movement Analysis
  • 5.2 Children
    • 5.2.1 Children Market, 2018 - 2030 (USD Million)
  • 5.3 Adults
    • 5.3.1 Adult Market, 2018 - 2030 (USD Million)

Chapter 6 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Attention Deficit Hyperactivity Disorder Market: Distribution Channel Movement Analysis
  • 6.2 Retail Pharmacy
    • 6.2.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3 Hospital Pharmacy
    • 6.3.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Market Size, Forecasts, and Revenue & Trend Analysis, 2022 to 2030
    • 7.3.1 North America
      • 7.3.1.1 North America Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.1.2 U.S.
      • 7.3.1.2.1 U.S. Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.1.3 Canada
      • 7.3.1.3.1 Canada Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.2 Europe
      • 7.3.2.1 Europe Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.2 UK
      • 7.3.2.2.1 UK Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.3 Germany
      • 7.3.2.3.1 Germany Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.4 Spain
      • 7.3.2.4.1 Spain Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.5 France
      • 7.3.2.5.1 France Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.6 Italy
      • 7.3.2.6.1 Italy Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.3 Asia Pacific
      • 7.3.3.1 Asia Pacific Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.2 Japan
      • 7.3.3.2.1 Japan Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.3 China
      • 7.3.3.3.1 China Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.4 India
      • 7.3.3.4.1 India Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.5 Australia
      • 7.3.3.5.1 Australia Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.6 South Korea
      • 7.3.3.6.1 South Korea Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.4 Latin America
      • 7.3.4.1 Latin America Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.2 Brazil
      • 7.3.4.2.1 Brazil Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.3 Mexico
      • 7.3.4.3.1 Mexico Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.4 Argentina
      • 7.3.4.4.1 Argentina Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.5 MEA
      • 7.3.5.1 MEA Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.2 South Africa
      • 7.3.5.2.1 South Africa Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.3 Saudi Arabia
      • 7.3.5.3.1 Saudi Arabia Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.4 UAE
      • 7.3.5.4.1 UAE Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 8 Attention Deficit Hyperactivity Disorder Market: Competitive Analysis

  • 8.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 8.1.1 Synergy Analysis: Major Deals and Strategic Alliances
      • 8.1.1.1 New Product Launches
      • 8.1.1.2 Mergers and Acquisitions
      • 8.1.1.3 Licensing Agreements
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
    • 8.2.3 Emerging Players
    • 8.2.4 Heat Map Analysis
  • 8.3 Company Market Position Analysis
  • 8.4 Vendor Landscape
    • 8.4.1 List of Key Distributors and Channel Partners
    • 8.4.2 List of Potential End-Users
    • 8.4.3 Key Company Market Share Analysis, 2022
    • 8.4.4 Consumer Behavior Analysis
    • 8.4.5 Competitive Dashboard Analysis
  • 8.5 Private Companies
    • 8.5.1 List of Key Emerging Companies
    • 8.5.2 Regional Network Map
  • 8.6 Company Profiles
    • 8.6.1 Pfizer, Inc.
      • 8.6.1.1 Company Overview
      • 8.6.1.2 Financial Performance
      • 8.6.1.3 Product Benchmarking
      • 8.6.1.4 Recent Developments
    • 8.6.2 Johnson & Johnson Services, Inc.
      • 8.6.2.1 Company Overview
      • 8.6.2.2 Financial Performance
      • 8.6.2.3 Product Benchmarking
      • 8.6.2.4 Recent Developments
    • 8.6.3 Lupin
      • 8.6.3.1 Company Overview
      • 8.6.3.2 Financial Performance
      • 8.6.3.3 Product Benchmarking
      • 8.6.3.4 Recent Developments
    • 8.6.4 Novartis AG
      • 8.6.4.1 Company Overview
      • 8.6.4.2 Financial Performance
      • 8.6.4.3 Product Benchmarking
      • 8.6.4.4 Recent Developments
    • 8.6.5 Takeda Pharmaceutical Company Limited
      • 8.6.5.1 Company Overview
      • 8.6.5.2 Shire plc
      • 8.6.5.3 Financial Performance
      • 8.6.5.4 Product Benchmarking
      • 8.6.5.5 Recent Developments
    • 8.6.6 Mallinckrodt plc.
      • 8.6.6.1 Company Overview
      • 8.6.6.2 Financial Performance
      • 8.6.6.3 Product Benchmarking
    • 8.6.7 Purdue Pharma L.p.
      • 8.6.7.1 Company Overview
      • 8.6.7.2 Product Benchmarking
    • 8.6.8 NEOS Therapeutics, Inc.
      • 8.6.8.1 Company Overview
      • 8.6.8.2 Financial performance
      • 8.6.8.3 Product Benchmarking
      • 8.6.8.4 Recent Developments
    • 8.6.9 Supernus Pharmaceuticals, Inc.
      • 8.6.9.1 Company Overview
      • 8.6.9.2 Financial performance
      • 8.6.9.3 Product Benchmarking
      • 8.6.9.4 Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 FDA-approved Amphetamine Drugs for ADHD
  • Table 5 5 FDA-approved Methylphenidate Drugs for ADHD
  • Table 6 FDA-Approved Non-Stimulants Drugs for ADHD
  • Table 7 Wholesale Prices of Prescription ADHD Medications
  • Table 8 List of Parameters
  • Table 9 List of Distributors
  • Table 10 Global Attention Deficit Hyperactivity Disorder Market, By Region, 2018 - 2030 (USD Million)
  • Table 11 Global Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 12 Global Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 13 Global Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 North America Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 15 North America Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 16 North America Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 17 North America Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18 U.S. Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 19 U.S. Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 20 U.S. Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 Canada Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 22 Canada Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 23 Canada Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 Europe Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 25 Europe Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 26 Europe Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Germany Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 29 Germany Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 30 Germany Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 UK Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 32 UK Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 33 UK Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 France Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 35 France Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 36 France Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Italy Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 38 Italy Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Spain Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 41 Spain Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Japan Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 48 Japan Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 49 Japan Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 China Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 51 China Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 52 China Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 India Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 54 India Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 55 India Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 South Korea Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 57 South Korea Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 58 South Korea Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Australia Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 60 Australia Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 61 Australia Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Latin America Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Latin America Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 64 Latin America Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 65 Latin America Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Brazil Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 67 Brazil Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 68 Brazil Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Mexico Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 70 Mexico Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 71 Mexico Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 73 Argentina Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 74 Argentina Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 South Africa Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 83 South Africa Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 84 South Africa Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 UAE Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 86 UAE Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 87 UAE Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Attention Deficit Hyperactivity Disorder (ADHD) Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Commodity Flow Approach
  • Fig. 10 Market Snapshot (2022) (USD Million)
  • Fig. 11 Segment Snapshot (2022) (USD Million)
  • Fig. 12 Competitive Snapshot
  • Fig. 13 Penetration & Growth Prospect Mapping
  • Fig. 14 ADHD Market Driver Impact
  • Fig. 15 ADHD Market Restraint Impact
  • Fig. 16 PESTEL Analysis
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 Attention Deficit Hyperactivity Disorder (ADHD) Drug Type Outlook: Key Takeaways
  • Fig. 19 Attention Deficit Hyperactivity Disorder Market: Drug Type Movement Analysis (USD Million)
  • Fig. 20 Stimulants Market 2018 - 2030 (USD Million)
  • Fig. 21 Amphetamine Market, 2018 - 2030 (USD Million)
  • Fig. 22 Methylphenidate Market, 2018 - 2030 (USD Million)
  • Fig. 23 Lisdexamfetamine Market, 2018 - 2030 (USD Million)
  • Fig. 24 Dexmethylphenidate Market, 2018 - 2030 (USD Million)
  • Fig. 25 Non - stimulants Market, 2018 - 2030 (USD Million)
  • Fig. 26 Atomoxetine Market, 2018 - 2030 (USD Million)
  • Fig. 27 Guanfacine Market, 2018 - 2030 (USD Million)
  • Fig. 28 Clonidine Market, 2018 - 2030 (USD Million)
  • Fig. 29 Others Market, 2018 - 2030 (USD Million)
  • Fig. 30 Attention Deficit Hyperactivity Disorder Demographic Outlook: Key Takeaways
  • Fig. 31 Attention Deficit Hyperactivity Disorder Market: Demographic Movement Analysis (USD Million)
  • Fig. 32 Children (2 - 17 years) Market, 2018 - 2030 (USD Million)
  • Fig. 33 Adult Market, 2018 - 2030 (USD Million)
  • Fig. 34 Attention Deficit Hyperactivity Disorder Distribution Channel Outlook: Key Takeaways
  • Fig. 35 Attention Deficit Hyperactivity Disorder Market: Distribution Channel Analysis (USD Million)
  • Fig. 36 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 37 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Snapshot, 2022 & 2030
  • Fig. 39 Regional Market Place: Key takeaways
  • Fig. 40 North America
  • Fig. 41 North America Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD million)
  • Fig. 42 U.S.
  • Fig. 43 U.S. Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada
  • Fig. 45 Canada Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD million)
  • Fig. 46 Europe
  • Fig. 47 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 48 U.K.
  • Fig. 49 U.K. Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany
  • Fig. 51 Germany Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 52 Spain
  • Fig. 53 Spain Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 54 France
  • Fig. 55 France Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 56 Italy
  • Fig. 57 Italy Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific
  • Fig. 59 Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan
  • Fig. 61 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 62 China
  • Fig. 63 China Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 64 India
  • Fig. 65 India Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 66 Australia
  • Fig. 67 Australia Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea
  • Fig. 69 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America
  • Fig. 71 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil
  • Fig. 73 Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 74 Mexico
  • Fig. 75 Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina
  • Fig. 77 Argentina Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 78 Middle East & Africa
  • Fig. 79 MEA Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa
  • Fig. 81 South Africa Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia
  • Fig. 83 Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 84 UAE
  • Fig. 85 UAE Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 86 Heat Map Analysis
  • Fig. 87 Company Market Position Analysis, 2022
  • Fig. 88 Company Market Position Analysis, 2022
  • Fig. 89 Company Market Share Analysis (2022)
  • Fig. 90 Consumer Behavior Analysis
  • Fig. 91 Market Differentiators